Pelthos Therapeutics Inc. (PTHS) Financials

PTHS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 137.4 million 138.9 million
March 31, 2026 145.4 million 110.3 million
Dec. 31, 2025 130.4 million 91.5 million
Sept. 30, 2025 126.4 million 68.2 million

PTHS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -7.7 million ?
March 31, 2026 -13.3 million 1.9 million
Dec. 31, 2025 -6.4 million 1.8 million
Sept. 30, 2025 -15.3 million 2.8 million

PTHS Net Income

No data available :(

PTHS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 24.6 million - -
March 31, 2026 32.2 million - 3.3 million
Dec. 31, 2025 18.0 million - 3.4 million
Sept. 30, 2025 14.3 million - 3.5 million

PTHS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 3.5 million
March 31, 2026 3.3 million
Dec. 31, 2025 3.2 million
Sept. 30, 2025 640518

PTHS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2000 600000 - -
March 31, 2026 194000 186000 13.3 million 4.2 million
Dec. 31, 2025 99000 374000 12.9 million 2.9 million
Sept. 30, 2025 - 145000 12.0 million 4.9 million

PTHS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 15.6 million 4.9 million
March 31, 2026 10.9 million 5.3 million
Dec. 31, 2025 9.4 million 4.4 million
Sept. 30, 2025 7.4 million 5.0 million

PTHS

Price: $20.15

52 week price:
18.19
37.50

Earnings Per Share: -28.63 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 73.0 million

Links: